Blog

Congresso dell’American Heart Association Scientific Sessions

CHICAGO
5 - 7 novembre 2022

Congresso dell'American Heart Association Scientific Sessions

Image

Gentili sostenitori e amici,

come sapete, siamo da poco tornati dal congresso dell'American Heart Association Scientific Sessions, che quest'anno si è tenuto a Chicago, dal 5 al 7 novembre 2022.

Per la Fondazione è stata un’ottima opportunità di presentare i risultati delle nostre ricerche alla comunità scientifica internazionale.

I nostri 3 lavori riguardavano:

    1. la microalbuminuria come predittore di prognosi con 22 anni di follow up dopo infarto miocardico acuto.
    2. la relazione tra scompenso cardiaco nell'infarto miocardico acuto e insorgenza di neoplasia maligna.
    3. la differenza di incidenza di neoplasia maligna in 6 diverse aree del Veneto nel post infarto.

Tutti e 3 gli argomenti hanno riscontrato interesse, con scambio proficuo di idee per le prossime attività.

La nostra fondazione ci tiene a ringraziare tutte le persone (e Istituzioni Pubbliche) che ci aiutano e ci sostengono in questi progetti.
Potrete trovare qui sotto delle diapositive riassuntive delle presentazioni.

Per ogni cosa ed eventuali idee-proposte di ricerca contattateci alla mail: abcstudyfoundation@gmail.com.

A tutti voi il più caro saluto.
Grazie a nome della Fondazione

Giuseppe Berton, MD, FESC,

Differences in Cancer Death Risk Long After ACS Among Selected Urban and Rural Areas in North Italy: The ABC-7a Study on Heart Disease

Background: An increased risk of cancer death has been demonstrated for patients
diagnosed with acute coronary syndrome (ACS). We are investigating possible
geographic risk disparities.
Methods: This prospective study included 541 ACS patients who were admitted to
hospitals and discharged alive in three provinces of Italy’s Veneto region. The patients
were classified as residing in urban or rural areas in each province.
Results: With 3 exceptions, all patients completed the 22-year follow-up or were followed
until death. Urban (46%) and rural (54%) residents shared most of their baseline
demographic and clinical characteristics. Pre-existing malignancy was noted in 15
patients, whereas 106 patients developed cancer during the follow-up period, which
represented 6232 person-years. No difference in the cancer death risk was found
between the urban and rural areas or between southern and northern provinces
(hazard ratio [HR] 1.1; 95% confidence interval [CI] 0.7–1.7; p = 0.59 and HR 1.1; 95%
CI 0.9–1.4; p = 0.29, respectively) according to the unadjusted Cox regression analysis.
Geographic areas, however, showed a strong positive interaction, with risk increasing
from the urban to rural areas from southern to northern provinces (HR 1.9; 95% CI 1.1–
3.0; p = 0.01). The fully adjusted Cox regression and Fine-Gray competing risk regression
models provided similar results. Interestingly, these results persisted, and even
strengthened, after exclusion of the 22 patients who developed malignancy and
survived to the end of follow-up. We did not observe an urban/rural difference in nonneoplastic
death risk or a significant interaction between the geographic areas.
Conclusion: Our analysis reveals that the cancer death risk among unselected ACS
patients in Italy’s Veneto region significantly differs by geography. The northern rural area
has the highest risk. These results highlight the importance of implementing a preventive
policy based on area-specific knowledge.